These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Impaired intracortical transmission in G2019S leucine rich-repeat kinase Parkinson patients. Ponzo V; Di Lorenzo F; Brusa L; Schirinzi T; Battistini S; Ricci C; Sambucci M; Caltagirone C; Koch G Mov Disord; 2017 May; 32(5):750-756. PubMed ID: 28186666 [TBL] [Abstract][Full Text] [Related]
4. Leucine-Rich Repeat Kinase (LRRK2) Genetics and Parkinson's Disease. Monfrini E; Di Fonzo A Adv Neurobiol; 2017; 14():3-30. PubMed ID: 28353276 [TBL] [Abstract][Full Text] [Related]
5. LRRK2 and the new era of Parkinson's disease research. The Lancet Neurology Lancet Neurol; 2016 Nov; 15(12):1195. PubMed ID: 27751534 [No Abstract] [Full Text] [Related]
6. Enteric alpha-synuclein pathology in LRRK2-G2019S Parkinson's disease. Rouaud T; Clairembault T; Coron E; Neunlist M; Anheim M; Derkinderen P Parkinsonism Relat Disord; 2017 Jul; 40():83-84. PubMed ID: 28483388 [No Abstract] [Full Text] [Related]
7. Wild-type LRRK2 as a new potential therapeutic target in idiopathic Parkinson's disease. Sanjari Moghaddam H; Aarabi MH Mov Disord; 2018 Dec; 33(12):1876. PubMed ID: 30452792 [No Abstract] [Full Text] [Related]
11. [Parkinson's disease associated to mutation of the LRRK2 gene, mimicking multisystemic atrophy due to the combination of parkinsonism, early-onset dysautonomia and normal cardiac scintigraphy]. Vilas D; Muxi A; Tolosa E; Compta Y Rev Neurol; 2016 Jul; 63(2):95-6. PubMed ID: 27377986 [No Abstract] [Full Text] [Related]
12. A novel rare variant of LRRK2 associated with familial Parkinson's disease: p.R1501W. Masuzugawa S; Nishioka K; Imai Y; Ogata J; Shojima Y; Li Y; Yoshino H; Hattori N Parkinsonism Relat Disord; 2020 Jul; 76():46-48. PubMed ID: 32563051 [No Abstract] [Full Text] [Related]
16. LRRK2 G2019S Mutation Inhibits Degradation of α-Synuclein in an In Vitro Model of Parkinson's Disease. Hu D; Niu JY; Xiong J; Nie SK; Zeng F; Zhang ZH Curr Med Sci; 2018 Dec; 38(6):1012-1017. PubMed ID: 30536063 [TBL] [Abstract][Full Text] [Related]
17. Generation of 2 induced pluripotent stem cell lines derived from patients with Parkinson's disease carrying LRRK2 G2385R variant. Cheng YC; Huang CY; Ho MC; Hsu YH; Syu SH; Lu HE; Lin HI; Lin CH; Hsieh PCH Stem Cell Res; 2018 Apr; 28():1-5. PubMed ID: 29414410 [TBL] [Abstract][Full Text] [Related]
18. Movement disorders rounds: A case of missing pathology in a patient with LRRK2 Parkinson's disease. Agin-Liebes J; Cortes E; Vonsattel JP; Marder K; Alcalay RN Parkinsonism Relat Disord; 2020 May; 74():76-77. PubMed ID: 31734038 [No Abstract] [Full Text] [Related]
19. LRRK2 Expression Is Deregulated in Fibroblasts and Neurons from Parkinson Patients with Mutations in PINK1. Azkona G; López de Maturana R; Del Rio P; Sousa A; Vazquez N; Zubiarrain A; Jimenez-Blasco D; Bolaños JP; Morales B; Auburger G; Arbelo JM; Sánchez-Pernaute R Mol Neurobiol; 2018 Jan; 55(1):506-516. PubMed ID: 27975167 [TBL] [Abstract][Full Text] [Related]
20. Neuromelanin magnetic resonance imaging of the substantia nigra in LRRK2-related Parkinson's disease. Correia Guedes L; Reimão S; Paulino P; Nunes RG; Bouça-Machado R; Abreu D; Gonçalves N; Soares T; Fabbri M; Godinho C; Pita Lobo P; Neutel D; Quadri M; Coelho M; Rosa MM; Campos J; Outeiro TF; Sampaio C; Bonifati V; Ferreira JJ Mov Disord; 2017 Sep; 32(9):1331-1333. PubMed ID: 28686310 [No Abstract] [Full Text] [Related] [Next] [New Search]